Supplementary Figure 4 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment

Supplementary Figure 4 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment

<p>Figure S4 shows the gating strategy of monocytes sorted from BAFF-expressing and control tumors</p>

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριος συγγραφέας:	Wei Liu (20030) (author)
Άλλοι συγγραφείς:	Paweł Stachura (8480817) (author), Haifeng C. Xu (7373933) (author), Renáta Váraljai (15194397) (author), Prashant Shinde (3707917) (author), Nikkitha Umesh Ganesh (15194400) (author), Matthias Mack (148002) (author), Anke Van Lierop (15194403) (author), Anfei Huang (461244) (author), Balamurugan Sundaram (440602) (author), Karl S. Lang (8444004) (author), Daniel Picard (14938665) (author), Ute Fischer (15194406) (author), Marc Remke (3508145) (author), Bernhard Homey (31953) (author), Alexander Roesch (2416078) (author), Dieter Häussinger (15194409) (author), Philipp A. Lang (7373936) (author), Arndt Borkhardt (2891) (author), Aleksandra A. Pandyra (8444013) (author)
Έκδοση:	2025
Θέματα:	Cancer Tumor Biology Immuno-oncology Immunology Cytokines Myeloid-derived suppressor cells NK cells Tumor immunology animal models Tumor-associated macrophages Skin Cancers Melanoma Tumor Microenvironment Cytokines and the microenvironment
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια

Supplementary Figure 1 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
ανά: Wei Liu (20030)
Έκδοση: (2025)

Supplementary Figure 2 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
ανά: Wei Liu (20030)
Έκδοση: (2025)

Supplementary Figure 3 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
ανά: Wei Liu (20030)
Έκδοση: (2025)

Supplementary Figure 5 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
ανά: Wei Liu (20030)
Έκδοση: (2025)

Supplementary Figure 6 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
ανά: Wei Liu (20030)
Έκδοση: (2025)

Supplementary Figure7 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
ανά: Wei Liu (20030)
Έκδοση: (2025)

Supplementary Table 1 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
ανά: Wei Liu (20030)
Έκδοση: (2025)

Supplementary Table 2 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
ανά: Wei Liu (20030)
Έκδοση: (2025)

Supplementary Table 3 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
ανά: Wei Liu (20030)
Έκδοση: (2025)

Supplementary figures and tables FTS1 from Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial
ανά: Daniel S. Green (15047598)
Έκδοση: (2025)

Supplementary Figures SF1-SF9 from Therapeutic Targeting of LIF Overcomes Macrophage-mediated Immunosuppression of the Local Tumor Microenvironment
ανά: Robin M. Hallett (15037427)
Έκδοση: (2025)

Supplementary Tables ST1-ST6 from Therapeutic Targeting of LIF Overcomes Macrophage-mediated Immunosuppression of the Local Tumor Microenvironment
ανά: Robin M. Hallett (15037427)
Έκδοση: (2025)

Supplementary Figure S1 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
ανά: Sonia A. Patel (15055688)
Έκδοση: (2025)

Supplementary Figure S2 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
ανά: Sonia A. Patel (15055688)
Έκδοση: (2025)

Supplementary Figure S3 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
ανά: Sonia A. Patel (15055688)
Έκδοση: (2025)

Supplementary Figure S4 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
ανά: Sonia A. Patel (15055688)
Έκδοση: (2025)

Supplementary Figure S5 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
ανά: Sonia A. Patel (15055688)
Έκδοση: (2025)

Figure S1 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
ανά: Dahihm Kim (16546203)
Έκδοση: (2025)

Figure S2 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
ανά: Dahihm Kim (16546203)
Έκδοση: (2025)

Figure S3 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
ανά: Dahihm Kim (16546203)
Έκδοση: (2025)

Figure S4 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
ανά: Dahihm Kim (16546203)
Έκδοση: (2025)

Figure S5 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
ανά: Dahihm Kim (16546203)
Έκδοση: (2025)

Table S1 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
ανά: Dahihm Kim (16546203)
Έκδοση: (2025)

Table S3 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
ανά: Dahihm Kim (16546203)
Έκδοση: (2025)

Supplementary Data 1 from Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti–PD-1–Resistant Advanced Melanoma
ανά: Alexander N. Shoushtari (15023909)
Έκδοση: (2025)

Supplementary video from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
ανά: Min Wu (14962986)
Έκδοση: (2025)

Table S1 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
ανά: Min Wu (14962986)
Έκδοση: (2025)

Table S2 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
ανά: Min Wu (14962986)
Έκδοση: (2025)

Table S3 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
ανά: Min Wu (14962986)
Έκδοση: (2025)

Supplementary Figures from Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell Subsets
ανά: Defne Bayik (14961098)
Έκδοση: (2025)

Supplementary Table S1 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
ανά: Hansol Lee (15054787)
Έκδοση: (2025)

Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
ανά: Hansol Lee (15054787)
Έκδοση: (2025)

Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
ανά: Hansol Lee (15054787)
Έκδοση: (2025)

Supplementary Table S4 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
ανά: Hansol Lee (15054787)
Έκδοση: (2025)

Supplementary Figure S1 from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases
ανά: James S. Wilmott (15008931)
Έκδοση: (2025)

Supplementary Tables S1-7 from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases
ανά: James S. Wilmott (15008931)
Έκδοση: (2025)

Supplementary file 1_Single-cell transcriptomics identifies FOSL1-regulated IGFBP3+ melanoma subtype as a neuro-immunoregulatory signaling hub facilitating tumor progression.docx
ανά: Wenjia Ge (22687361)
Έκδοση: (2025)

Supplementary Table S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
ανά: Jonathan M.J. Derry (16648337)
Έκδοση: (2025)

Supplementary Table S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
ανά: Jonathan M.J. Derry (16648337)
Έκδοση: (2025)

Supplementary Table S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
ανά: Jonathan M.J. Derry (16648337)
Έκδοση: (2025)

Cannot write session to /tmp/vufind_sessions/sess_1kmqlone06sot1fpv5ttmafrvi